AUROPHARMA is an NSE/BSE-listed stock covered on WealthJot with a daily-updated technical scorecard, price chart, and momentum signals.

Is AUROPHARMA a buy or sell right now?

See the Technical Scorecard above for AUROPHARMA's current momentum grade, RSI, and MACD signal — it is recomputed daily from price data, not a fixed recommendation.

Where can I see AUROPHARMA financials, news, and insider trades?

Financials, earnings, insider trades, news, and peer comparisons for AUROPHARMA are available in the tabs below the price chart.

Aurobindo Pharma Ltd. (AUROPHARMA) Share Price, News & Quote

Aurobindo Pharma Ltd. (AUROPHARMA) Share Price, News & Quote - WealthJot

Technical Scorecard

as of 2026-08-04B+7.1/10

AUROPHARMA returned 39.0% over 1 year as of 2026-08-04.

Price trend+39.0%

₹1,561₹1,114

Aug 25Aug 26

Momentum

6.5

GoodRSI(14) = 51

Trend

8.0

Excellent5.4% below 52-week high

Strength

5.0

AverageADX(14) = 25

Volume

7.0

Good1.9× average volume

Structure

9.0

Excellentabove 200-DMA · above 50-DMA

Why this grade?

Strongest: Structure — above 200-DMA · above 50-DMA
Weakest: Strength — ADX(14) = 25

Similar to AUROPHARMAView all peers

SUNPHARMAB+LAURUSLABSB+PPLPHARMAB+ZYDUSLIFEB

AUROPHARMA — returns by timeframe

	1W	1M	3M	6M	1Y
AUROPHARMA	-3.8%	+1.5%	+14%	+20%	+20.3%

AUROPHARMA — position in its 52-week range

₹1016.1₹1396.7₹1550

AUROPHARMA — RSI(14) momentum

RSI(14) · below 30 oversold · above 70 overbought

Mutual funds holding this stock

Holding as % of the fund's portfolio · latest disclosure

NH0.04%

PHARMDEX0.04%

SHOF0.04%

HEALETF0.04%

AXISHETF0.04%

MIDETF0.03%

Metric	Value
Price (LTP)	₹1,548.3
52-week high	₹1,636.8
52-week low	₹1,016.1
P/E (TTM)	—
Market cap	—